Károly Fazekas

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 358 citations

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15

Béla Kiss, I. Laszlovszky, Attila Horváth et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 60 citations

Psychiatry, I. Neurochemical Characterisation, Medicine +10

<p>Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine</p>

Béla Kiss, Zsolt Némethy, Károly Fazekas et al. · Drug Design Development and Therapy · 2019 · 48 citations · Full text

Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis

Károly Fazekas, Orsolya Csuka, István Köves et al. · Clinical & Experimental Metastasis · 2000 · 45 citations

Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma

Balázs Döme, Beáta Somlai, Andrea Ladányi et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2001 · 32 citations

Tumor Biology, Human Melanoma, Medicine +9